Patients who received etanercept exhibited a greater reduction in MRI-based scores for sacroiliac joint inflammation ( -@ % versus -@ % ; P < @ ) and spinal inflammation ( -@ % versus -@ % ; P = @ ) compared with placebo-treated patients at week @ .